Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study

By Andersen J.T.   Ekman P.   Wolf H.   Beisland H.O.   Johansson J.E.   Kontturi M.   Lehtonen T.   Tveter K.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 631-637

Elsevier

Access to resources Recommend Favorite

Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia

By Feneley M.R.   Dunsmuir W.D.   Pearce J.   Kirby R.S.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 658-663

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

By Roehrborn C.G.   for the ALFUS STUDY GROUP  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite